Inspec

Inspec EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Inspec (6656.T) as of Oct 21, 2026 is -8.06. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 6.83 — a change of -218.07% (lower).

EV/OCF

-8.06

YoY

-218.07%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Inspec is 2026 -8.06 . EV/OCF (Enterprise Value to Operating Cash Flow) of Inspec was 2025 6.83 . It decreases by -218.07% lower compared to the previous year.

The Inspec EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2019
4.54 JPY
Jan 1, 2020
27.64 JPY
Jan 1, 2021
-19.69 JPY
Jan 1, 2022
-20.07 JPY
Jan 1, 2023
-6.88 JPY
Jan 1, 2024
39.44 JPY
Jan 1, 2025
6.83 JPY
Jan 1, 2026
-8.06 JPY
The Inspec EV/OCF history
YEAREV/OCFYoY
-8.06-218.07%
6.83-82.69%
39.44-673.25%
-6.88-65.73%
-20.07+1.94%
-19.69-171.23%
27.64+509.07%
4.54-167.93%
-6.68-191.02%
7.34-61.06%
18.85-161.00%
-30.91+144.49%
-12.64—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Inspec is -8.06 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of Inspec changed from 6.83 to -8.06, representing a -218.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Inspec since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Inspec with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Inspec

All Key Metrics — Inspec